X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE UNICHEM LAB SUVEN LIFE/
UNICHEM LAB
 
P/E (TTM) x 20.2 -64.6 - View Chart
P/BV x 4.4 0.7 609.6% View Chart
Dividend Yield % 0.5 2.3 22.1%  

Financials

 SUVEN LIFE   UNICHEM LAB
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
UNICHEM LAB
Mar-18
SUVEN LIFE/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs251382 65.7%   
Low Rs155234 66.2%   
Sales per share (Unadj.) Rs49.1116.3 42.2%  
Earnings per share (Unadj.) Rs9.7-18.9 -51.4%  
Cash flow per share (Unadj.) Rs11.4-11.7 -97.0%  
Dividends per share (Unadj.) Rs1.505.00 30.0%  
Dividend yield (eoy) %0.71.6 45.5%  
Book value per share (Unadj.) Rs60.3381.0 15.8%  
Shares outstanding (eoy) m127.2870.34 180.9%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.12.6 155.9%   
Avg P/E ratio x20.9-16.3 -128.2%  
P/CF ratio (eoy) x17.8-26.2 -67.9%  
Price / Book Value ratio x3.40.8 416.2%  
Dividend payout %15.4-26.4 -58.4%   
Avg Mkt Cap Rs m25,82521,668 119.2%   
No. of employees `0001.12.3 47.0%   
Total wages/salary Rs m6132,006 30.5%   
Avg. sales/employee Rs Th5,832.63,587.8 162.6%   
Avg. wages/employee Rs Th571.5880.0 64.9%   
Avg. net profit/employee Rs Th1,153.8-583.7 -197.7%   
INCOME DATA
Net Sales Rs m6,2538,180 76.4%  
Other income Rs m233610 38.1%   
Total revenues Rs m6,4858,790 73.8%   
Gross profit Rs m1,982-1,320 -150.1%  
Depreciation Rs m213505 42.2%   
Interest Rs m4680 57.8%   
Profit before tax Rs m1,955-1,295 -150.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m71833 2,149.2%   
Profit after tax Rs m1,237-1,331 -92.9%  
Gross profit margin %31.7-16.1 -196.4%  
Effective tax rate %36.7-2.6 -1,423.9%   
Net profit margin %19.8-16.3 -121.6%  
BALANCE SHEET DATA
Current assets Rs m5,62223,318 24.1%   
Current liabilities Rs m1,1684,635 25.2%   
Net working cap to sales %71.2228.4 31.2%  
Current ratio x4.85.0 95.7%  
Inventory Days Days81122 66.9%  
Debtors Days Days36121 29.6%  
Net fixed assets Rs m3,3258,163 40.7%   
Share capital Rs m127141 90.5%   
"Free" reserves Rs m7,54726,660 28.3%   
Net worth Rs m7,67426,801 28.6%   
Long term debt Rs m143 421.2%   
Total assets Rs m9,13531,890 28.6%  
Interest coverage x43.2-15.2 -284.9%   
Debt to equity ratio x00 1,471.0%  
Sales to assets ratio x0.70.3 266.8%   
Return on assets %14.0-3.9 -358.1%  
Return on equity %16.1-5.0 -324.6%  
Return on capital %26.0-4.5 -573.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,0664,356 116.3%   
Fx outflow Rs m2,0010-   
Net fx Rs m3,0654,356 70.4%   
CASH FLOW
From Operations Rs m699-1,123 -62.3%  
From Investments Rs m-616,487 -0.0%  
From Financial Activity Rs m-577-8,811 6.5%  
Net Cashflow Rs m1166,552 1.8%  

Share Holding

Indian Promoters % 63.4 50.1 126.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.1 -  
FIIs % 0.0 3.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 31.7 115.1%  
Shareholders   37,287 20,176 184.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  ELDER PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Hurricanes Threaten Oil Spike, but the Saudis are Selling...(Vivek Kaul's Diary)

Sep 6, 2018

Oil prices are rising and could go even more higher amid rising tensions in Middle East.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Sep 19, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS